Preclinical: IRX5010 tumor growth inh... - Advanced Prostate...

Advanced Prostate Cancer

21,580 members27,007 posts

Preclinical: IRX5010 tumor growth inhibiting anti-cancer immune responses inducer in multiple types of cancers

Maxone73 profile image
0 Replies

Tested on prostate cancer models as well

globenewswire.com/news-rele...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Boron Inhibits Tumor-induced Angiogenesis

angiogenesis prevents growth of many types of solid tumors and provides a novel approach for cancer...

Glutamine-blocking drug slows tumor growth and strengthens anti-tumor response

and eventually die. Cancer cells’ addiction to glutamine has long tempted cancer biologists as a...

Anti-Androgen Therapy and Bone Tumors in Prostate Cancer

target treatments for men with different types of prostate cancer,” he said. “The findings also...

Piperlongumine inhibits cell growth and enhances TRAIL-induced apoptosis in prostate cancer cells

https://www.apjtb.org/article.asp?issn=2221-1691;year=2020;volume=10;issue=5;spage=216;epage=223;aul

Put another way: Tumor growth can be a byproduct of cancer treatments that kill tumor cells.

Eradicating Cancer: Leave No Dead Cells Behind;...